ARTELO BIOSCIENCES INC (ARTL) Stock Analyst Earnings Estimates
NASDAQ:ARTL - Nasdaq - US04301G5080 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 410.04% | N/A 53.02% | N/A 58.46% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -2.34M | -3.21M -37.18% | -4.69M -46.11% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -20K | -20K | -30K -50.00% | -230K -666.67% | -2.34M -917.39% | -3.21M -37.18% | -4.69M -46.11% | -7.44M -58.64% | -10.29M -38.31% | -9.93M 3.50% | -10M -0.70% | N/A -7.10% | N/A -71.43% | N/A -30.56% | N/A -6.38% | N/A 111.35% | N/A 5,569.89% | N/A 68.10% | N/A 78.51% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | -1.01 36.53% | -0.29 71.29% | -21.90 -7,451.72% | -19.14 12.60% | -18.30 4.39% | N/A 51.17% | N/A 64.38% | N/A 21.15% | N/A 24.39% | N/A 109.68% | N/A 5,133.33% | N/A 42.68% | N/A 41.52% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -4.27 5.03% | -5.62 -167.63% | -0.49 93.03% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.346M 6.53% | -2.55M -113.39% | -2.877M 24.52% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -4.32 7.69% | -0.80 | -3.52 | -442.99% |
| Q4 2024 Q2Q % growth | -7.02 -12.50% | -2.67 | -4.35 | -162.68% |
| Q3 2024 Q2Q % growth | -2.10 57.83% | -2.84 | 0.74 | 25.94% |
| Q2 2024 Q2Q % growth | -4.50 -33.93% | -5.18 | 0.68 | 13.15% |
| Q1 2024 Q2Q % growth | -4.68 -2.63% | -6.46 | 1.78 | 27.52% |
| Q4 2023 Q2Q % growth | -6.24 11.86% | -3.41 | -2.83 | -83.16% |
| Q3 2023 Q2Q % growth | -4.98 -1.22% | -3.96 | -1.02 | -25.83% |
| Q2 2023 Q2Q % growth | -3.36 37.78% | -4.99 | 1.63 | 32.64% |
| Q1 2023 Q2Q % growth | -4.56 -1.33% | -5.69 | 1.13 | 19.88% |
| Q4 2022 Q2Q % growth | -7.08 -10,014.29% | -4.47 | -2.61 | -58.47% |
| Q3 2022 Q2Q % growth | -4.92 -9,740.00% | -5.59 | 0.67 | 11.98% |
| Q2 2022 Q2Q % growth | -5.40 -17,900.00% | -5.20 | -0.20 | -3.80% |
| Q1 2022 Q2Q % growth | -4.50 -3,114.29% | -7.80 | 3.30 | 42.33% |
| Q4 2021 Q2Q % growth | -0.07 65.00% | -0.06 | -0.01 | -24.78% |
| Q3 2021 Q2Q % growth | -0.05 81.48% | -0.10 | 0.05 | 49.29% |
| Q2 2021 Q2Q % growth | -0.03 92.50% | -0.09 | 0.06 | 67.32% |
| Q1 2021 Q2Q % growth | -0.14 65.00% | -0.12 | -0.02 | -19.35% |
| Q4 2020 Q2Q % growth | -0.20 33.33% | -0.10 | -0.10 | -96.08% |
| Q3 2020 Q2Q % growth | -0.27 -58.82% | -0.37 | 0.10 | 26.47% |
| Q2 2020 Q2Q % growth | -0.40 -135.29% | -0.41 | 0.01 | 1.96% |
| Q1 2020 Q2Q % growth | -0.40 | -0.54 | 0.14 | 26.01% |
| Q3 2019 Q2Q % growth | -0.17 | -0.52 | 0.35 | 67.32% |
| Q2 2019 Q2Q % growth | -0.17 | -0.43 | 0.26 | 60.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -3123.08% | -3123.08% | -25.86% | -655.17% |
| Revenue | N/A | N/A | N/A | N/A |